Anorexia nervosa (AN) and bulimia nervosa (BN) are eating disorders (ED) with complex genetic and environmental components. Genetic studies and animal models support the participation of brain-derived neurotrophic factor (BDNF) in the vulnerability to AN and BN. We investigated the genetic contribution of the BDNF-specific receptor neurotrophic tyrosine kinase receptor type 2 (NTRK2) to the susceptibility to ED. We have screened the entire NTRK2 gene in 91 patients with ED and have identified 14 single-nucleotide polymorphisms (SNPs). A population-based association study with six SNPs from the NTRK2 locus was performed in 164 ED patients and 121 controls. Significant evidence of association for markers -69C4G and IVS13 þ 40G4A was detected. We also observed a strong association between the C-A-insC haplotype (-69/IVS13 þ 40/2784-2785) and binge-eating/purging AN (ANP, P ¼ 0.006; OR ¼ 2.27), and a reduced frequency of haplotype G-A-delCl in BN patients (P ¼ 0.034; OR ¼ 0.6). The analysis of ED-related phenotypes revealed a clear association between NTRK2, high scores of Harm avoidance measured by the temperament and character inventory (TCI-R; P ¼ 0.003) and minimum body mass index (minBMI; Po0.001). Our data support a contribution of NTRK2 to the genetic susceptibility of ED, mainly ANP, and ED-related phenotypic traits, such as Harm avoidance and minBMI. Keywords: anorexia; bulimia; eating disorders; harm avoidance; BDNF; NTRK2 Eating disorders (ED) are complex psychiatric diseases characterized by alterations in eating behaviour, body shape perception and body weight regulation. Different genetic, psychological and environmental factors contribute to the vulnerability to both anorexia nervosa (AN) and bulimia nervosa (BN), but the pathophysiology of these disorders is still largely unknown. 1 Brain-derived neurotrophic factor (BDNF) encodes for a neurotrophic factor expressed in the hypothalamic nuclei that regulate eating behaviour and modulates synaptic efficiency and neuronal plasticity through the control of different neurotransmitter systems previously involved in ED.
Eating disorders (ED) are complex psychiatric diseases characterized by alterations in eating behaviour, body shape perception and body weight regulation. Different genetic, psychological and environmental factors contribute to the vulnerability to both anorexia nervosa (AN) and bulimia nervosa (BN), but the pathophysiology of these disorders is still largely unknown. 1 Brain-derived neurotrophic factor (BDNF) encodes for a neurotrophic factor expressed in the hypothalamic nuclei that regulate eating behaviour and modulates synaptic efficiency and neuronal plasticity through the control of different neurotransmitter systems previously involved in ED. 2, 3 Intraventricular administration of Bdnf induces appetite suppression and body weight reduction in rats, while Bdnf knockout mice develop obesity associated to hyperphagia and serotonin dysfunctions. [3] [4] [5] Moreover, we and others have previously reported a strong association between BDNF and both AN and BN in different populations. [6] [7] [8] [9] Due to the strong association between BDNF and ED, we propose its high-affinity receptor neurotrophic tyrosine kinase receptor type 2 (NTRK2) as a candidate gene to participate in the aetiology of ED and suggest that alterations on its function or expression pattern could contribute to the development of AN and BN. Different lines of evidences support this hypothesis. NTRK2 is expressed in hypothalamic neurons that control food intake and energy expenditure. Infusion of the Ntrk2 specific ligands, Bdnf or Nt4/5, transiently reverse the eating behaviour and obesity of the Bdnf (7) knockout mice and the reduction of the Ntrk2 expression in the R BZ/ R BZ mutant mice, which only express the full-length Ntrk2 isoform at approximately a quarter of the normal amount, leads to obesity and hyperphagia. 2, 3 We present here the screening of the entire NTRK2 gene in patients with ED and show evidence of association of a specific NTRK2 haplotype with binge-eating/purging AN and a reduced frequency of another haplotype in BN patients. Moreover, the analysis of some ED-related phenotypes revealed a clear association between NTRK2, Harm avoidance and minimum body mass index (minBMI), supporting the contribution of this BDNF high-affinity receptor to the genetic susceptibility of ED.
Materials and methods

Study subjects
The clinical group consisted of 164 Spanish Caucasian ED patients that were consecutively admitted and diagnosed in the Psychiatric Unit of the 'Princeps d'Espanya Hospital' between April 1999 and April 2002. All subjects fulfilled DSM-IV criteria for ED (Diagnostic and Statistical Manual for Mental Disorders, 4th edn) and were diagnosed using the Structured Clinical Interview for Mental disorders (SCID-I, research version 2.0). The sample consisted of 81 BN patients (49.4%; 78 purging versus three nonpurging BN) and 83 AN patients (50.6%; 39 restricting subtype and 44 binge/eating purging subtype). More than 3 years of restricting illness were necessary to classified patients as ANR. Diagnosis was blind to genotype. Most of patients were female (n ¼ 156; 93%). Clinical information was available from most of the patients. The average age at assessment was 25 2) for AN cases. In total, 87 ED patients (47 AN and 37 BN) of the total clinical sample completed the Temperamental and Character inventory (TCI-R) and were considered to determine the NTRK2 participation in different personality traits. Most of patients have been studied in previous reports. [6] [7] [8] 10, 11 The control sample consisted of 121 Caucasian unrelated subjects matched for ethnicity and sex (93% females; n ¼ 113). The study was approved by the ethics committee of our Institution ('Ciutat Sanitaria i Universitaria Bellvitge') and written informed consent was obtained from all subjects.
NTRK2 genomic organization
The genomic organization of the NTRK2 gene was in silico determined by the sequence similarity search program PSI-BLAST. The exon-intron boundaries were predicted from public database sequences by alignment of the human chromosome 9 genomic sequence (GenBank Accession No. 37539725) and the cDNA sequences of NTRK2 (GenBank Accession Nos. 18369862, 15217076, 18369866, 18369864 and 21886727).
Molecular studies
In total, 26 primer pairs covering the entire coding region, the exon-intron boundaries and the 5 0 and 3 0 untranslated regions of the NTRK2 gene were designed (Supplementary Table S1 ). Table S1 ). Subsequently, gels were silver stained and those samples showing an abnormal SSCP banding patterns were re-amplified, sequenced with a commercial kit (Applied Biosystems) and analyzed on an automatic sequencer (ABI PRISM 337XL). In order to avoid type I errors, the NTRK2 contribution to the different temperamental dimensions was assessed by the following strategy using the SPSS 10.0 statistical package: we first determined the effect of the C-A-insC high-risk haplotype in the four temperament dimensions measured by TCI-R (Novelty-seeking, Harm avoidance, Reward dependence and Persistence) through two-way analysis of variance (ANOVA) stratified by the clinical subtype of AN or BN. Once we detected a possible participation of NTRK2 in any of the personality traits, we separately considered both AN and BN groups by one-way ANOVA, taking into account the associated personality trait and its specific subscales. After Borferroni correction, considering four temperamental traits or subscales, significance was set at Po0.0125. The restricting or binge-eating/purging AN phenotypes were not considered in the analysis of personality traits due to the reduced sample size. Mean scores of AO, minBMI and maxBMI were compared between patients carrying the different NTRK2 SNPs and noncarriers by t-tests using the statistical package SPSS 10.0. Since three ED-related phenotypes and six markers were analysed, corrected P-values were considered statistically significant when below 0.003.
Statistical analysis
Results
To investigate the possible involvement of NTRK2 in eating behaviour, we 'in silico' determined the genomic organization of the human NTRK2 gene. NTRK2 maps to human chromosome 9q22.1, spans 353 kb and is composed by 21 exons that, through alternative splicing and the usage of distinct promoters and polyadenilation sites, generate five distinct mRNA isoforms encoding five different proteins: three truncated (NTRK2-T1, NTRK2-T2a and NTRK2-T2b) and two complete forms (NTRK2a and NTRK2b).
NTRK2 exons are organized in six different blocks. The first block contains exons 1 and 2, the promoter region and the translation initiation site. The second block is composed by exons 3-12 and encodes for the extracellular domain and the juxtamembrane region of the NTRK2 receptor. Exon 13, which is located 60 kb downstream from exon 12, corresponds to the third block and generates the NTRK2-T1 truncated isoform. The next block is composed by exons 14 and 15, which encode for the intracellular juxtamembane domain, and exon 16 that generates the NTRK2-T2a and NTRK2-T2b truncated isoforms, depending on alternative splicing of exon 14. Finally, the following block corresponds to exons 17-19 that encode for the tyrosine kinsase domain and are separated by 65 kb from exons 20 and 21, which encode for the carboxy-terminus of the tyrosine kinase domain and a gamma phospholipase C binding site ( Figure 1 ).
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In order to identify sequence variants with a potential involvement in ED we screened by PCR-SSCP, the 21 exons of the NTRK2 gene, including the 5 0 untranslated region, the coding exons and the intron-exon flanking areas, in a total sample of 91 ED patients. By sequencing the PCR products with an abnormal electrophoretic mobility we identified 14 different SNPs ( Figure 1 , Table 1 ). For sequence variants identified in more than one patient but with a minor allele frequency of less than 10% (IVS1 þ 434A4G, -279G4T, IVS17-7T4C and 1800C 4A), a sample of 90 sex-matched unrelated controls were genotyped. Only those NTRK2 SNPs with a minor allele frequency higher than 10% were considered for a case-control association study. Thus, the initial screened group of 91 ED patients was increased to a total sample of 164 unrelated cases. This disease group and 121 unrelated controls, Table 1 SNPs identified within the NTRK2 gene through a PCR-SSCP mutational screening in a total sample of 91 ED patients Under the hypothesis that NTRK2 may confer vulnerability to ED subtypes by different mechanisms and to reduce heterogeneity, ED patients were subdivided into three main diagnostic groups for statistical analyses: restricting AN (ANR), binge/ eating purging AN (ANP) and BN. [14] [15] [16] Consistent with the physical distance between SNPs, linkage disequilibrium (LD) analysis showed that À69G4C and IVS2 þ 40C4T, and IVS17À125T4 C and IVS18 þ 13G4A SNPs were in strong LD (D 0 ¼ 1; Table 2 ). All sequence variants were in Hardy-Weinberg equilibrium and showed statistical (Table 3 ). However, we detected an increased number of patients carrying the À69C allele of the À69C4G SNP, differences that were statistically significant when we considered both genotype (2P ¼ 0.038) and allele frequencies (2P ¼ 0.016; OR ¼ 1.89) of this SNP in the ANP group. We also observed that genotype frequencies of the IVS13 þ 40G4 A SNP significantly differed from controls when the BN sample was considered (2P ¼ 0.034; Table 3 ). However, after the most conservative multiple comparison correction, taking into account six SNPs and three diagnostic groups, the À69G4C and IVS13 þ 40G4A sequence variants did not remain positively associated to ED. We further performed a haplotype-based analysis, which has increased statistical power than the comparison of individual markers. 17 In order to avoid low haplotype frequencies and considering the LD patterns, we analyzed those SNPs with minor allele frequencies higher than 20%. Thus, the À69C4G, IVS13 þ 40G4A and 2784-2785insC SNPs, which span the entire NTRK2 gene, were used to estimate haplotypes. These SNPs showed eight possible allelic combinations, four of which consisting of common haplotypes, covering more than 90% of the total NTRK2 haplotype diversity (Table 4) . Once we compared haplotypes frequencies, no significant differences were observed when the ANR sample was compared to controls. Nevertheless, consistent with the study of individual markers, haplotype frequencies significantly differed from controls when the ANP (2P ¼ 0.027) and the BN (2P ¼ 0.045) groups were analyzed (Table 4) . Of these, the C-A-insC haplotype was over-represented in the ANP sample when compared to controls (2P ¼ 0.006; OR ¼ 2.27), while the G-A-delC haplotype was less frequent in the BN sample than in controls (2P ¼ 0.034; OR ¼ 0.6; Table 5 ), results that suggest a potential protective effect of this haplotype against the disease.
As we had found association between ED and both BDNF [6] [7] [8] and NTRK2 genes in the same set of Spanish patients, we further determined possible epistatic effects between the C-A-insC NTRK2 haplotype and the Met66 allele of the BDNF gene by a stepwise logistic regression analysis. Thus, we evaluated the contribution of BDNF and NTRK2 as predictors of the illness status by comparing two logistic regression models with a LR test: in the first model we considered the C-A-insC haplotype and the Val66Met polymorphism as independent or predictive variables, while in the second model we included the interaction C-A-insC*Val66Met in the equation. The log of the likelihood ratio for both genes in predicting the ED phenotype was 0.97 (w 2 ¼ 1.9, df ¼ 1, P ¼ 0.17), results that do not support the participation of epistatic effects between BDNF and NTRK2 in the risk to develop AN or BN (data not shown). 18 we examined the contribution of the high-risk C-AinsC haplotype in ED through the modulation of different temperamental traits measured by the Temperament and Character Inventory (TCI-R 19 ). The analysis of the variance (ANOVA) showed no significant differences between carriers and noncarriers of this NTRK2 risk haplotype when the Novelty seeking, Reward dependence and Persistence dimensions were considered. In contrast, we observed a strong association between Harm avoidance and the C-A-insC allelic combination (F ¼ 9.4; P ¼ 0.003; Table  6 ). When considering the ED clinical subtypes separately, no significant differences were observed in the AN group (data not shown). However, bulimic patients carring the C-A-insC haplotype showed higher scores not only in Harm avoidance (HA; P ¼ 0.001) but also in two of its subscales: Anticipatory Worry and Pessimism versus Uninhibited Optimism (HA1; P ¼ 0.017) and Fear of Uncertainty (HA2; Po0.001; Table 7 ).
Under the hypothesis that the different diagnostic groups may not determine genetically distinct entities, but consist of a single broad phenotype with shared susceptibility factors, we examined the relationship between NTRK2 SNPs and different phenotypical traits associated to an increased severity of the illness, such as minBMI, maxBMI and AO. While no significant effect on AO was observed, the mean minBMI and maxBMI were significantly higher i n ED patients carrying the 2784-2785insC and IVS17À125T4C alleles, respectively (2P ¼ 0.001 for 2784-2785insC and 2P ¼ 0.033 for IVS17À125T4C; Table 8 ). After Bonferroni correction, considering three different phenotypes and six SNPs, only the 2784-2785insC variant was still positive associated to minBMI.
Discussion
The present study provides evidence for a strong association between the NTRK2 gene and ED, mainly ANP and some ED-related phenotypes such as Harm avoidance and minBMI. These data suggest that 
a Analysis stratified by the clinical subtype of AN or BN. *Bold denotes statistically significant after Bonferroni correction (Po0.0125). 
a Anticipatory worry and pessimism versus uninhibited optimism. b Fatigability and asthenia versus vigour. *Statistically significant after Bonferroni correction (Po0.0125).
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NTRK2 SNPs with functional consequences on its expression patterns, activity or affinity to BDNF may participate in the development and maintenance of ED. Through a mutational screening of the 21 NTRK2 exons in 91 patients with ED, we have identified 14 different SNPs in this gene. These include two silent mutations, 171A4G and 1888C4A, in two patients with ANP and BN, that may not play an essential role in the modulation of the protein function; two variants located within the 5 0 untranslated region (5 0 UTR), À279G4T and À69C4G, that did not alter any previously described consensus sequence. The exact role of these SNPs is unknown; however, they could modulate the NTRK2 translation or transcription efficiency, the temporal and tissue-specific expression pattern or the stability of the different mRNA isoforms; an insertion of a cytosine within the 3 0 UTR, 2784À2785insC, which may have post-transcriptional consequences associated to the full-length NTRK2 isoforms; 20 a transition SNP, IVS2 þ 3G4A, within the consensus donor splicing site of exon 2 that may be implicated in the splicing function of intron 2, and eight intronic SNPs. Although a few lines of investigation have focused the study on polymorphisms within intronic sequences, there are strong evidences for the existence of transcription regulatory elements within these regions that suggest them as good candidates for association studies. [21] [22] [23] Single-marker analysis revealed significant evidences for nominal association between the À69C4 G and IVS13 þ 40G4A SNPs and both ANP and BN, respectively. Moreover, the haplotype-based association study reflected the single-locus results with an over-representation of the C-A-insC haplotype in the ANP sample and a reduced frequency of the G-A-delC allelic combination in BN patients. This suggests the presence of protective or low-risk haplotypes and could reflect a possible participation of the C-A-insC haplotype in the susceptibility to BN. This hypothesis is supported by the fact that both purging clinic subtypes (ANP and BN) share different personality and psychopathological traits and by the positive association between the C-A-insC haplotype and high scores of Harm avoidance observed in the BN patients. [14] [15] [16] A strong relationship between ED and some personality traits has been described. [24] [25] [26] We report here that BN patients carrying the NTRK2 high-risk haplotype C-A-insC display high scores in Harm 27, 28 These results support the involvement of NTRK2 in the development of ED, not only through a direct participation in food intake and body weight regulation, as suggested by animal models, but also through the modulation of different personality traits that may increase the risk of AN and BN, such as depression or anxiety.
The comparison of the C-A-insC high-risk haplotype and the G-A-delC protective haplotype suggests the contribution of the À69G4C and 2784-2785insC sequence variants in the vulnerability to ED. This hypothesis is also supported by the strong association observed between the 2784-2785insC SNP and minBMI. Nevertheless, it is also possible that these NTRK2 SNPs may not confer functional alterations, but are in linkage disequilibrium with other yet unknown susceptibility variants directly involved in the genetic vulnerability to ED. No evidence for functional consequences of the À69G4C and 2784-2785insC SNPs have been described; however, we would expect that NTRK2 alterations associated to ED may lead to a more severe effect than variations on the BDNF gene. This hypothesis is based on the fact that the NTRK2 receptor also binds with high affinity to NT4/5, neurotrophin with a similar expression pattern than BDNF that could participate in different compensatory mechanisms. 29 Moreover, since NTRK2 also binds to NT3, alterations in its function or expression pattern may affect other neurotrophic systems than the BDNF/NTRK2 signalling pathway. 30 The lack of association after correcting for multiple comparisons when the different NTRK2 SNPs were independently considered raises several methodological considerations. Bonferroni correction taking into account three clinical categories (ANR, ANP and BN) and six different SNPs may be too stringent to detect the participation of genetic factors in the aetiology of a complex disease such as ED, where several susceptibility genes with a moderated effect are expected. Moreover, the consideration of Bonferroni correction in our study may be unnecessary due to the strong disequilibrium among the different NTRK2 SNPs and the fact that the different ED clinical subgroups are not independent factors, one of the requirements for the application of this statistical correction.
Although other groups have focus investigations in the study of the BDNF participation in different psychiatric conditions, [31] [32] [33] [34] to our knowledge this is the first study that proposes its high-affinity receptor NTRK2 as a candidate gene for psychiatric disorders and suggest its involvement in ED, minBMI and Harm avoidance. The participation of NTRK2 in eating behaviour and weight regulation is based on work on animal models and the population-based association study reported here. NTRK2 is expressed in hypothalamic neurons that control food intake and energy expenditure, infusion of Ntrk2 specific ligands transiently reverse the obesity phenotype of the Bdnf (7) knockout mice and reductions in the Ntrk2 expression in the R BZ/ R BZ mutant mice lead to obesity associated to hyperphagia. 2, 3 These evidences support that BDNF or NTRK2 sequence variants associated to ANR may lead to gain-of-function alterations on this neurotrophic signalling pathway. However, it remains uncertain which is the exact role of this neurotrophic system in the purging ED subtypes (ANP and BN). An increased BDNF activity could participate in the starvation periods of these categories or, alternatively, reductions on this neurotrophic function and its effect on its downstream mediators may lead to the binge episodes and loss of satiety present in ANP and BN patients. This last hypothesis would suggest a differential participation of the BDNF/NTRK2 system in the purging (ANP and BN) and nonpurging (ANR) ED subtypes. This is supported by the different contribution of the serotoninergic system in ED, where an hyperserotoninergic function participates in the aetiology of ANR and reductions of this neurotransmitter signalling are implicated in the compulsive food intake and binge episodes characteristics of the ANP and BN patients. [35] [36] [37] [38] [39] [40] We and others have previously reported a strong association between BDNF and ED in several populations. [6] [7] [8] [9] These observations, together with the strong association of its specific receptor NTRK2 and ANP, support that SNPs affecting this neurotrophic system may contribute in the genetic susceptibility to ED. Nevertheless, we found no evidences of epistatic effects between BDNF and NTRK2, suggesting that, although having similar consequences in eating behaviour, the presence of susceptibility alleles in both genes do not increase the risk that each variant may confer to the vulnerability to ED. However, these findings should be considered preliminary until replicated in different sets of patients, family trios and other populations as it has occurred with BDNF. [6] [7] [8] [9] Once confirmed, functional studies would provide additional information about the mechanisms by which alterations in the BDNF/NTRK2 signalling pathway contribute to the vulnerability to ED. In addition, the consideration of possible protective NTRK2 allelic combinations against the disease and their effect on its downstream mediators may be important as potential therapeutic targets for ED.
